RxDoctor Payments Data

Audrey Green-Murphy

Pediatric Hematology-Oncology · Madera, CANPI 1912297003

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $50,800 of the $76,584 with a category attached, or 66.3%. AstraZeneca accounts for 85.8% of it on its own, with 20 other manufacturers making up the rest. Among pediatric hematology-oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$76,584in general payments, 2019–2025

Across 123 payments — averaging $622.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$66K
  • Springworks Therapeutics, Inc.$8K
  • Day One Biopharmaceuticals$2K
  • Servier Pharmaceuticals LLC$262
  • Genentech USA, Inc.$147
  • Jazz Pharmaceuticals Inc.$104
  • plus $498 from 15 others

What the payments were for

  • Consulting fees$13,16817%
  • Speaking & faculty fees$50,80066%
  • Travel & lodging$10,02213%
  • Food & beverage$2,5943%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,584 in reported general payments places this provider in the 90th percentile of 307 pediatric hematology-oncology providers in California.

See all pediatric hematology-oncology providers in California →

Other pediatric hematology-oncology in Madera

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →